Ovation Science Inc.
OVAT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 65.20K | 83.00K | 82.40K | 75.10K | 45.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.20K | 83.00K | 82.40K | 75.10K | 45.70K |
| Cost of Revenue | 5.40K | 20.20K | 29.50K | 28.50K | 28.80K |
| Gross Profit | 59.80K | 62.80K | 52.90K | 46.60K | 16.90K |
| SG&A Expenses | 368.40K | 402.40K | 495.30K | 520.40K | 567.00K |
| Depreciation & Amortization | 1.00K | 1.60K | 2.20K | 2.40K | 2.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 377.50K | 433.50K | 511.40K | 541.60K | 605.10K |
| Operating Income | -312.40K | -350.60K | -429.10K | -466.70K | -559.50K |
| Income Before Tax | -289.50K | -335.40K | -471.80K | -485.20K | -624.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.29 | -0.34 | -0.47 | -0.49 | -0.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -289.50K | -335.40K | -471.80K | -485.20K | -624.90K |
| EBIT | -312.40K | -350.60K | -429.10K | -466.70K | -559.50K |
| EBITDA | -310.60K | -348.60K | -426.90K | -464.30K | -557.10K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 134.85M | 134.06M | 131.97M | 126.10M | 126.10M |
| Average Diluted Shares Outstanding | 134.85M | 134.06M | 131.97M | 126.10M | 126.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |